Carlos R. Hernandez-Duarte
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals.
Journal: Scientific reports
Published: April 16, 2024
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.
Journal: Science advances
Published: December 21, 2022
Identification of novel neutralizing determinants for protection against HCV.
Journal: Hepatology (Baltimore, Md.)
Published: May 06, 2022
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals.
Journal: iScience
Published: April 21, 2022
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.
Journal: Vaccines
Published: December 20, 2021
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.
Journal: Antimicrobial agents and chemotherapy
Published: June 07, 2021
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
Journal: Vaccines
Published: April 19, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026